Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Clin Gastroenterol Hepatol. 2017 Dec;15(12):1882-1889.e1. doi: 10.1016/j.cgh.2017.06.028. Epub 2017 Jun 19.
BACKGROUND & AIMS: We performed a retrospective cohort study of patients with and without gastrointestinal bleeding (GIB) to determine whether GIB increases the risks of thromboembolism and death.
We collected data from 522 patients with acute severe GIB and 1044 patients without GIB (control subjects, matched for age, sex, year of diagnosis, history of thromboembolism, and use of antithrombotic drugs) who underwent endoscopy at the National Center for Global Health and Medicine in Japan from January 2009 through December 2014. Hazard ratios of GIB for thromboembolism and mortality risk were estimated, adjusting for confounders. We also compared standardized mortality ratios between the GIB cohort and the age- and sex-matched general population in Japan.
During a mean follow up of 23.7 months, thromboembolism was identified in 11.5% of patients with GIB and 2.4% of control subjects (hazard ratio, 5.3; 95% confidence interval, 3.3-8.5; P < .001). Multivariate analysis revealed GIB as a risk factor for all-thromboembolic events, cerebrovascular events, and cardiovascular events. During a mean follow-up of 24.6 months, 15.9% of patients with GIB and 8.6% of control subjects died (hazard ratio, 2.1; 95% confidence interval, 1.6-2.9; P < .001). Multivariate analysis revealed GIB as a risk factor for all-cause mortality. Compared with the general population, patients with GIB were at increased risk of death (standardized mortality ratio, 12.0).
In a retrospective analysis of patients undergoing endoscopy in Japan, we identified acute GIB was a significant risk factor for late thromboembolism and death, compared with patients without GIB. GIB also increased risk of death compared with the general population.
我们对伴有和不伴有胃肠道出血(GIB)的患者进行了回顾性队列研究,以确定 GIB 是否会增加血栓栓塞和死亡的风险。
我们收集了 2009 年 1 月至 2014 年 12 月在日本国立全球健康与医学中心接受内镜检查的 522 例急性重度 GIB 患者和 1044 例无 GIB(对照,年龄、性别、诊断年份、血栓栓塞史和抗血栓药物使用情况相匹配)患者的数据。调整混杂因素后,估计 GIB 发生血栓栓塞和死亡率的风险比。我们还比较了 GIB 队列与日本年龄和性别匹配的一般人群的标准化死亡率比。
在平均 23.7 个月的随访期间,GIB 患者中有 11.5%发生血栓栓塞,而对照组为 2.4%(风险比,5.3;95%置信区间,3.3-8.5;P<.001)。多变量分析显示 GIB 是所有血栓栓塞事件、脑血管事件和心血管事件的危险因素。在平均 24.6 个月的随访期间,GIB 患者中有 15.9%和对照组中有 8.6%死亡(风险比,2.1;95%置信区间,1.6-2.9;P<.001)。多变量分析显示 GIB 是全因死亡率的危险因素。与一般人群相比,GIB 患者的死亡风险增加(标准化死亡率比,12.0)。
在对日本接受内镜检查的患者进行的回顾性分析中,我们发现与无 GIB 患者相比,急性 GIB 是发生晚期血栓栓塞和死亡的显著危险因素。与一般人群相比,GIB 也增加了死亡的风险。